Chinook Therapeutics to Present at Upcoming Investor Conferences
SEATTLE, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in fireside chats and one-on-one meetings at the following upcoming investor conferences:
To access the audio webcasts and subsequent archived recording of these and other company presentations, please visit the Investors section of Chinook’s website. The archived audio webcasts will remain available for replay on Chinook’s website for 90 days.
About Chinook Therapeutics, Inc.
Contact: Noopur Liffick Vice President, Investor Relations & Corporate Communications [email protected] [email protected]
Session Details TBA
How to Build Cyber Security Awareness
Keynote Presentation by ThreatLocker: Zero Trust at the Endpoint: Fighting Ransomware